Literature DB >> 25904723

Early Childhood IQ Trajectories in Individuals Later Developing Schizophrenia and Affective Psychoses in the New England Family Studies.

Jessica C Agnew-Blais1, Stephen L Buka2, Garrett M Fitzmaurice3, Jordan W Smoller4, Jill M Goldstein5, Larry J Seidman6.   

Abstract

Individuals who develop schizophrenia in adulthood exhibit, on average, deficits in childhood cognition relative to healthy controls. However, it remains unclear when in childhood such deficits emerge and whether they are stable across childhood or change (increase or decrease) across development. Importantly, whether the trajectory of childhood cognition differs among youth who later develop affective psychoses (AP) vs schizophrenia as adults remains unresolved. Subjects in the Collaborative Perinatal Project were administered the Stanford-Binet IQ test at age 4 and the Wechsler Intelligence Scale for Children at age 7. A total of 9809 (54.7%) participants in the New England Study sites were tested at both ages, including 37 who later developed schizophrenia spectrum psychoses (SSP) and 39 who later developed AP. Logistic regression models examined the association of level of and change in childhood IQ and later SSP or AP. Lower overall childhood IQ was associated with higher risk of SSP. Additionally, there was a small mean increase in IQ in the SSP group relative to a mean decrease in the control group from age 4 to 7 such that positive change in IQ was significantly associated with a higher risk of SSP. Neither overall level nor change in IQ was associated with risk of AP. The results are consistent with neurocognitive impairment throughout early childhood specifically for children who later develop schizophrenia, affirming the theory of atypical neurodevelopment in premorbid schizophrenia.
© The Author 2015. Published by Oxford University Press on behalf of the Maryland Psychiatric Research Center. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  IQ; affective psychosis; cognition; cognitive development; schizophrenia

Mesh:

Year:  2015        PMID: 25904723      PMCID: PMC4466188          DOI: 10.1093/schbul/sbv027

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  27 in total

Review 1.  Premorbid indicators and risk for schizophrenia: a selective review and update.

Authors:  Matcheri S Keshavan; Vaibhav A Diwadkar; Debra M Montrose; Rajaprabhakaran Rajarethinam; John A Sweeney
Journal:  Schizophr Res       Date:  2005-11-01       Impact factor: 4.939

2.  Evidence for early-childhood, pan-developmental impairment specific to schizophreniform disorder: results from a longitudinal birth cohort.

Authors:  Mary Cannon; Avshalom Caspi; Terrie E Moffitt; HonaLee Harrington; Alan Taylor; Robin M Murray; Richie Poulton
Journal:  Arch Gen Psychiatry       Date:  2002-05

Review 3.  Neurocognition in the psychosis risk syndrome: a quantitative and qualitative review.

Authors:  Anthony J Giuliano; Huijun Li; Raquelle I Mesholam-Gately; Shannon M Sorenson; Kristen A Woodberry; Larry J Seidman
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

4.  Childhood cognitive functioning in schizophrenia patients and their unaffected siblings: a prospective cohort study.

Authors:  T D Cannon; C E Bearden; J M Hollister; I M Rosso; L E Sanchez; T Hadley
Journal:  Schizophr Bull       Date:  2000       Impact factor: 9.306

5.  Longitudinal assessment of premorbid cognitive functioning in patients with schizophrenia through examination of standardized scholastic test performance.

Authors:  Rebecca Fuller; Peg Nopoulos; Stephan Arndt; Dan O'Leary; Beng-Choon Ho; Nancy C Andreasen
Journal:  Am J Psychiatry       Date:  2002-07       Impact factor: 18.112

6.  Premorbid IQ in schizophrenia: a meta-analytic review.

Authors:  Kristen A Woodberry; Anthony J Giuliano; Larry J Seidman
Journal:  Am J Psychiatry       Date:  2008-04-15       Impact factor: 18.112

7.  Schizophrenia is a cognitive illness: time for a change in focus.

Authors:  René S Kahn; Richard S E Keefe
Journal:  JAMA Psychiatry       Date:  2013-10       Impact factor: 21.596

8.  Neuropsychological performance and family history in children at age 7 who develop adult schizophrenia or bipolar psychosis in the New England Family Studies.

Authors:  L J Seidman; S Cherkerzian; J M Goldstein; J Agnew-Blais; M T Tsuang; S L Buka
Journal:  Psychol Med       Date:  2012-05-11       Impact factor: 7.723

9.  Meta-analyses of cognitive and motor function in youth aged 16 years and younger who subsequently develop schizophrenia.

Authors:  H Dickson; K R Laurens; A E Cullen; S Hodgins
Journal:  Psychol Med       Date:  2011-09-06       Impact factor: 7.723

10.  Decline in cognitive performance between ages 13 and 18 years and the risk for psychosis in adulthood: a Swedish longitudinal cohort study in males.

Authors:  James H MacCabe; Susanne Wicks; Sofia Löfving; Anthony S David; Åsa Berndtsson; Jan-Eric Gustafsson; Peter Allebeck; Christina Dalman
Journal:  JAMA Psychiatry       Date:  2013-03       Impact factor: 21.596

View more
  14 in total

Review 1.  Perinatal Risks and Childhood Premorbid Indicators of Later Psychosis: Next Steps for Early Psychosocial Interventions.

Authors:  Cindy H Liu; Matcheri S Keshavan; Ed Tronick; Larry J Seidman
Journal:  Schizophr Bull       Date:  2015-04-22       Impact factor: 9.306

2.  Polygenic risk score increases schizophrenia liability through cognition-relevant pathways.

Authors:  Timothea Toulopoulou; Xiaowei Zhang; Stacey Cherny; Dwight Dickinson; Karen F Berman; Richard E Straub; Pak Sham; Daniel R Weinberger
Journal:  Brain       Date:  2019-02-01       Impact factor: 13.501

3.  The interplay of childhood behavior problems and IQ in the development of later schizophrenia and affective psychoses.

Authors:  Jessica Agnew-Blais; Larry J Seidman; Garrett M Fitzmaurice; Jordan W Smoller; Jill M Goldstein; Stephen L Buka
Journal:  Schizophr Res       Date:  2017-01-03       Impact factor: 4.939

4.  New Targets for Prevention of Schizophrenia: Is It Time for Interventions in the Premorbid Phase?

Authors:  Larry J Seidman; Merete Nordentoft
Journal:  Schizophr Bull       Date:  2015-04-29       Impact factor: 9.306

5.  Reduced model-based decision-making in schizophrenia.

Authors:  Adam J Culbreth; Andrew Westbrook; Nathaniel D Daw; Matthew Botvinick; Deanna M Barch
Journal:  J Abnorm Psychol       Date:  2016-05-12

6.  Neurocognitive profiles in the prodrome to psychosis in NAPLS-1.

Authors:  Eva Velthorst; Eric C Meyer; Anthony J Giuliano; Jean Addington; Kristin S Cadenhead; Tyrone D Cannon; Barbara A Cornblatt; Thomas H McGlashan; Diana O Perkins; Ming T Tsuang; Elaine F Walker; Scott W Woods; Carrie E Bearden; Larry J Seidman
Journal:  Schizophr Res       Date:  2018-08-02       Impact factor: 4.939

Review 7.  Progress and Future Directions in Research on the Psychosis Prodrome: A Review for Clinicians.

Authors:  Kristen A Woodberry; Daniel I Shapiro; Caitlin Bryant; Larry J Seidman
Journal:  Harv Rev Psychiatry       Date:  2016 Mar-Apr       Impact factor: 3.732

8.  Course of Cognitive Development From Infancy to Early Adulthood in the Psychosis Spectrum.

Authors:  Josephine Mollon; Anthony S David; Stanley Zammit; Glyn Lewis; Abraham Reichenberg
Journal:  JAMA Psychiatry       Date:  2018-03-01       Impact factor: 21.596

9.  Polygenic Risk Scores Differentiating Schizophrenia From Bipolar Disorder Are Associated With Premorbid Intelligence in Schizophrenia Patients and Healthy Subjects.

Authors:  Kazutaka Ohi; Daisuke Nishizawa; Shunsuke Sugiyama; Kentaro Takai; Ayumi Kuramitsu; Junko Hasegawa; Midori Soda; Kiyoyuki Kitaichi; Ryota Hashimoto; Kazutaka Ikeda; Toshiki Shioiri
Journal:  Int J Neuropsychopharmacol       Date:  2021-07-23       Impact factor: 5.176

Review 10.  Early interventions in risk groups for schizophrenia: what are we waiting for?

Authors:  Iris E Sommer; Carrie E Bearden; Edwin van Dellen; Elemi J Breetvelt; Sasja N Duijff; Kim Maijer; Therese van Amelsvoort; Lieuwe de Haan; Raquel E Gur; Celso Arango; Covadonga M Díaz-Caneja; Christiaan H Vinkers; Jacob As Vorstman
Journal:  NPJ Schizophr       Date:  2016-03-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.